USA - engelsk - NLM (National Library of Medicine)

endo pharmaceuticals inc. - acrivastine (unii: a20f9xai7w) (acrivastine - unii:a20f9xai7w), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - acrivastine 8 mg - semprex-d capsules are indicated for relief of symptoms associated with seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, and nasal congestion. semprex-d capsules should be administered when both the antihistaminic activity of acrivastine and the nasal decongestant activity of pseudoephedrine are desired (see clinical pharmacology ). the efficacy of semprex-d capsules beyond 14 days of continuous treatment in patients with seasonal allergic rhinitis has not been adequately investigated in clinical trials. semprex-d capsules have not been adequately studied for effectiveness in relieving the symptoms of the common cold. semprex-d capsules are contraindicated in patients with a known sensitivity to acrivastine, other alkylamine antihistamines (e.g., triprolidine), pseudoephedrine, other sympathomimetic amines (e.g., phenylpropanolamine), or to any other components of the formulation. semprex-d capsules are contraindicated in patients with severe hypertension or severe coronary arte

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

glaxo wellcome gmbh & co. kg - acrivastin - kapsel - acrivastin 8.mg

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

glaxo wellcome gmbh & co. kg - acrivastinhydrochlorid - lösung - acrivastinhydrochlorid 4.419mg

USA - engelsk - NLM (National Library of Medicine)

ucb, inc. - acrivastine (unii: a20f9xai7w) (acrivastine - unii:a20f9xai7w), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - capsule - 8 mg - semprex-d capsules are indicated for relief of symptoms associated with seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, and nasal congestion. semprex-d capsules should be administered when both the antihistaminic activity of acrivastine and the nasal decongestant activity of pseudoephedrine are desired (see clinical pharmacology). the efficacy of semprex-d capsules beyond 14 days of continuous treatment in patients with seasonal allergic rhinitis has not been adequately investigated in clinical trials. semprex-d capsules have not been adequately studied for effectiveness in relieving the symptoms of the common cold. semprex-d capsules are contraindicated in patients with a known sensitivity to acrivastine, other alkylamine antihistamines (e.g., triprolidine), pseudoephedrine, other sympathomimetic amines (e.g., phenylpropanolamine), or to any other components of the formulation. semprex-d capsules are contraindicated in patients with severe hypertension or severe coronary arter

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

ace pharmaceuticals b.v. schepenveld 41 3891 zk zeewolde schepenveld 41 3891 zk zeewolde () - acrivastine 8 mg/stuk - capsule, hard - gelatine (e 441) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; titaandioxide (e 171), dimeticon (e 900) ; gelatine (e 441) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; lactose 1-water ; lecithine (e 322) ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; schellak (e 904) ; titaandioxide (e 171), dimeticon (e 900) ; gelatine (e 441) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; lactose 1-water ; lecithine (e 322) ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; schellak (e 904) ; titaandioxide (e 171), - acrivastine

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

brown & burk uk ltd - acrivastine - oral capsule - 8mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - acrivastine - oral capsule - 8mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - acrivastine - oral capsule - 8mg

Malta - engelsk - Medicines Authority

mcneil products limited foundation park, roxborough way, maidenhead, berkshire sl6 3ug, united kingdom - acrivastine - capsule - acrivastine 8 mg - antihistamines for systemic use

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm generics a/s - acrivastin - kapsler, hårde - 8 mg